The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring ...

The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Could disrupting your internal clock be the key to treating Alzheimer’s? A surprising new study, published in the journal ...

Researchers used supramolecular nanoparticles to repair the brain’s vascular system and reverse Alzheimer’s in mice. Instead ...

Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

Since 2013, for the Walk to End Alzheimer’s, the “Jevning Gems” team, led by Val Blomquist of Hallock, Minnesota, has raised ...

Find out more about a new study's promising treatment. July 29, 2008— -- More than 5 million Americans have Alzheimer's disease and 10 million baby boomers are expected to develop it in the ...

Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease ...